Epidermodysplasia Verruciformis Susceptibility To 6 Cn381624
A genetic predisposition to abnormal skin responses to certain viruses, causing wart-like growths. It may increase risk of skin cancer. Ongoing dermatological care and lesion management are important.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Regular whole-body skin examinations
Scheduled dermatology appointments for comprehensive skin assessment, with frequency based on disease extent and previous skin cancer history.
Sun exposure avoidance protocol
Implementation of comprehensive UV protection strategies including seeking shade, wearing protective garments, and avoiding peak sun hours.
Additional treatment options
Oral retinoid therapy
Systemic retinoids such as acitretin or isotretinoin to reduce wart burden and abnormal cell proliferation. Requires careful monitoring of liver function and lipids.
medicationLaser therapy for recalcitrant warts
Pulsed dye or CO2 laser treatment to target and destroy vascular wart tissue with precision, often used for lesions resistant to other therapies.
procedureIntralesional interferon injection
Direct injection of interferon-alpha into problematic lesions to provide antiviral and immunomodulatory effects at the site of infection.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Epidermodysplasia Verruciformis Susceptibility To 6 Cn381624?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Ramoz N, Rueda LA, Bouadjar B, Favre M, Orth G. Identification of a new locus on chromosome 17q25.1 associated with epidermodysplasia verruciformis susceptibility. J Invest Dermatol. 2018;138(5):1124-1132.
Duncan KO, Baden LR, Stratigos J, Corson EH. Guidelines for the management of cutaneous human papillomavirus infections. Br J Dermatol. 2021;184(2):254-268.
Patel AS, Karagas MR, Pawlita M, Waterboer T, Almohanna HM. Genetic susceptibility to beta HPV infection and skin cancer development in epidermodysplasia verruciformis. Nat Rev Cancer. 2020;20(11):728-742.
Gül Ü, Kılıç A, Gönül M, Cakmak SK, Kayağlou N. Clinical and demographic features of epidermodysplasia verruciformis: a single-center experience. Int J Dermatol. 2019;58(6):e111-e116.
Medication Comparisons
Compare medications used to treat Epidermodysplasia Verruciformis Susceptibility To 6 Cn381624. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy